Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
5
×
boston top stories
life sciences
national blog main
national top stories
novartis
5
×
fda
indiana blog main
indiana top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
amgen
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cancer
europe blog main
europe top stories
genentech
ipo
10x genomics
abbvie
What
fda
5
×
medicines
drug
new
approval
bio
roundup
won
acquire
activity
address
agreed
amgen
approvals
approves
august
billion
biogen
biotech
blueprint
brings
busy
cancer
candidates
carries
cash
certain
cholesterol
clamped
class
company
compound
covid
days
deal
decisions
delays
designed
developed
developing
Language
unset
Current search:
photo
×
fda
×
" boston blog main "
×
novartis
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines